There were no statistically significant differences in the density of immunostaining for CD3+, CD4+, CD8+, CD45R0+, Foxp3+, CD20+, and CD163+ T cells in the adjacent tumor and malignant tumor except for CD8+ T cells (See Supplementary Table S1). The gene discussed is CD163; the disease is cancer.